Could CBD Be An Antibiotic?

The relationship between infection and standard prescription antibiotics

Could CBD be useful in the battle against resistant bacterial pressures? The arise from the University of Queensland in Australia suggest that it is possible. However before taking a look at the research study in depth, it works to comprehend the advancement of the relationship between germs and prescription antibiotics.

Since the revolutionary discovery of penicillin by Alexander Fleming in 1928, prescription antibiotics have been a vital tool in the battle against germs and infections. And although we still utilize the very same tested techniques today, germs have progressed. When exposed to prescription antibiotics, particular germs, fungi and parasites are able to adjust and cancel the effectiveness of the drug by establishing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to happen anyhow, as the genetic code for germs changes with time. However, it is believed that the overuse of prescription antibiotics is a crucial factor that speeds up the advancement of resistant pressures. See Nine CBD for further reading.

According to the World Health Organization, antimicrobial resistance “is an increasingly severe threat to worldwide public health that requires action in all sectors of federal government and in society.” This has actually led researchers to think outside package by trying to identify compounds that could be useful in the battle against hazardous germs. Among these compounds is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Scientists are trying to find brand-new ways to assault infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works against Gram-positive germs. Strains of Gram-positive germs include Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia). CBD Gurus is a good resource for this.

Dr. Blaskovich provided his findings at an annual conference of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with synthetic CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive pressures of resistant germs, which lots of standard prescription antibiotics are beginning to stop working.

” In specific, the activity was picked against the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to induce resistance and was active against MRSA biofilms. “

The team also conducted another research study utilizing topical CBD to treat a skin infection in mice. Once again, although the results were positive, CBD did not appear to get rid of the infection, however simply to reduce the variety of bacterial cells.

Could CBD become an antibiotic?

While it is simple to hail this work as a substantial development in the antibacterial abilities of CBD, it is prematurely to give up on penicillin.

Although it is believed that the effectiveness of CBD could come from the method it attacks the biofilm surrounding bacterial cells, the authors are still not sure of the mechanism of action of CBD. They also did not hesitate to explain the shortcomings of the research study. Dr. Blaskovich mentioned that since the results are in the preliminary stages, it is far too early for people to begin treating their CBD infections themselves.

The research study was also conducted in vitro (outside the human body), and there is a danger that the results of clinical trials will not be the same. Numerous compounds have revealed antibacterial efficacy in petri dishes, however then stopped working at this crucial stage. It should also be mentioned that the two studies were performed in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical business focusing on topical CBD products.

However, this research could be a crucial step forward for CBD and the battle against antimicrobial resistance. CBD continues to have a good safety profile and is not considered toxic even in large amounts. Fortunately, Dr. Blaskovich and his team plan to continue their research.

Scroll to top